Skip to main content

Advertisement

Log in

Disease-modifying drugs for rheumatoid arthritis Asset or liability?

  • Editorial
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Wooley, O.H., Griffin, J., Panayi, G.S., Batchelor, J.R., Welsh, K.I., Gibson, T.J., HLA-DR antigens and toxic reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. N Engl J Med 1980, 303, 300–302.

    CAS  PubMed  Google Scholar 

  2. Perrier, P., Raffoux, C., Thomas, Ph., Tamisier, J.N., Busson, M., Gaucher, A., Streiff, F., HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis. Ann Rheum Dis, 1985, 44, 621–624.

    CAS  PubMed  Google Scholar 

  3. Ayesh, R., Mitchell, S. C., Waring, R.H., Withrington, R.H., Seifert, M.H., Smith, L. Sodium aurothiomalate toxicity and sulphoxidation capacity in rheumatoid arthritis patients Br J Rheumatol 1987, 26, 197–201.

    CAS  PubMed  Google Scholar 

  4. Madhok, R., Capell, H.A., Waring, R. Does sulphoxidation state predict gold toxicity in rheumatoid arthritis? Br Med J 1987, 294, 483.

    CAS  Google Scholar 

  5. Srinivasan, R., Miller, B.L., Paulus, H.E. Long-term chrysotherapy in rheumatoid arthritis. Arthritis Rheum. 1979, 22, 105–110.

    CAS  PubMed  Google Scholar 

  6. Evers, A.E., Sundstrom, W.R. Second course gold therapy in the treatment of rheumatoid arthritis. Arthritis Rheum. 1983, 26, 1071–1075.

    CAS  PubMed  Google Scholar 

  7. Williame, L.M.E., Joos, R., Proot, F., Immesoete, C. Gold induced aplastic anaemia. Clin Rheumatol 1987, 6, 4, 600–605.

    CAS  PubMed  Google Scholar 

  8. Rubinstein, I., Langevitz, P., Pras, M., Aurothio-glucose overdosage in five patients with rheumatoid arthritis. Clin Rheumatol 1987, 6, 4, 583–587.

    CAS  PubMed  Google Scholar 

  9. Anon. Methotrexate for arthritis. Lancet, 1986, 1, 74–75.

  10. Weinstein, A. Reappraisal of the use of methotrexate in the management of rheumatoid arthritis. Int Med Special, 1986, 7, 79–84.

    Google Scholar 

  11. Willkens, R.F., Williams, H.J., Egger, M.J., Reading, J. C., Clements, P. J., Cathcart, E.S., Samuelson, C.O. Jr., Solsky, M.A., Kaplan, S.B., Guttadauria, M., Halla, J.T., Weinstein, A. Randomized, double-blind, placebo controlled trial of lowdose pulse methotrexate in psoriatic arthritis. Arthritis Rheum. 1984, 27, 376–381.

    CAS  PubMed  Google Scholar 

  12. Leonard, P.A., Clegg, D.O., Carson, C., Cannon, G.W., Egger, M.J., Ward, J.R. Low dose pulse methotrexate in rheumatoid arthritis: an 8 year experience with hepatotoxicity. Clin Rheumatol 1987, 6, 4, p. 575–582.

    CAS  PubMed  Google Scholar 

  13. Weinstein, A., Marlowe, S., Korn, J., Farouhar, F. Low dose methotrexate treatment of rheumatoid arthritis: long-term observations. Am J Med 1985, 79, 331–337.

    Article  CAS  PubMed  Google Scholar 

  14. Bitter, T. Combined disease-modifying chemotherapy for intractable rheumatoid arthritis. Clin Rheum Dis 1984, 10, 417–428.

    CAS  PubMed  Google Scholar 

  15. McCarty, D.J., Carrera, G.F. Intractable rheumatoid Arthritis: treatment with combined cyclophosphamide, azathioprine and hydroxychloroquine. J A M A 1982, 248, 1718–1723.

    CAS  PubMed  Google Scholar 

  16. Binder, A.I., SO, A., Ansell, B.M., Denman, A.M. Intensive immunosuppression in intractable rheumatoid arthritis. Br J Rheumatol 1986, 25, 380–383.

    CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Disease-modifying drugs for rheumatoid arthritis Asset or liability?. Clin Rheumatol 6, 486–488 (1987). https://doi.org/10.1007/BF02330584

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02330584

Navigation